Charles A. Deignan - 13 Sep 2023 Form 4 Insider Report for Clearside Biomedical, Inc. (CLSD)

Role
Chief Financial Officer
Signature
/s/ Mark Ballantyne, Attorney-in-Fact
Issuer symbol
CLSD
Transactions as of
13 Sep 2023
Net transactions value
+$13,636
Form type
4
Filing time
13 Sep 2023, 18:55:33 UTC
Previous filing
20 Jan 2023
Next filing
20 Sep 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CLSD Common Stock Options Exercise $13,636 +34,090 +9.4% $0.4000 397,562 13 Sep 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLSD Employee Stock Option (right to buy) Options Exercise $0 -34,090 -100% $0.000000* 0 13 Sep 2023 Common Stock 34,090 $0.4000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Fully vested and exercisable.